RPG Life Sciences Limited has announced its financial results for the quarter and year ended March 31st, 2020.
RPG Life Sciences, engaged in the manufacturing and marketing of pharmaceutical products, posted its Q4 and Full year results. Q4 revenue is higher by 29% than the corresponding quarter last year and PBT before exceptional items has registered around 4 fold jump from Rs 2.12 crores to Rs 8.46 crores.
For full year, revenue at Rs 375.57 crores grew by 14% and PBT before exceptional item at Rs 41.77 crores was almost 2.8x times of last year.
"For the year FY2020, the company registered a turnaround performance led by the biggest contributing Domestic business, which grew over 23%, much ahead of the market growth. Product portfolio rejuvenation, focus on prescription generation and sales force effectiveness enhancement were the key contributors. Overall for the company, all 4 quarters recorded fairly consistent sales and profit performance." said Mr. Yugal Sikri, Managing Director, RPG Life Sciences Ltd.
Shares of RPG LIFE SCIENCES LTD. was last trading in BSE at Rs.282 as compared to the previous close of Rs. 273.05. The total number of shares traded during the day was 13223 in over 875 trades.
The stock hit an intraday high of Rs. 294 and intraday low of 276. The net turnover during the day was Rs. 3720441.